Identification of p53 Sequence Elements That Are Required for MDM2-Mediated Nuclear Export

REFERENCES

• Argentini, M., N. Barboule, and B. Wasylyk. 2001. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability. Oncogene 20:1267–1275.
   PubMed Web of Science ®Google Scholar
• Ashcroft, M., and K. H. Vousden. 1999. Regulation of p53 stability. Oncogene 18:7637–7643.
   PubMed Web of Science ®Google Scholar
• Boyd, S. D., K. Y. Tsai, and T. Jacks. 2000. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell. Biol. 2:563–568.
   PubMed Web of Science ®Google Scholar
• Cho, Y., S. Gorina, P. D. Jeffrey, and N. P. Pavletich. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346–355.
   PubMed Web of Science ®Google Scholar
• Freedman, D. A., and A. J. Levine. 1998. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18:7288–7293.
   PubMed Web of Science ®Google Scholar
• Geyer, R. K., Z. K. Yu, and C. G. Maki. 2000. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell. Biol. 2:569–573.
   PubMed Web of Science ®Google Scholar
• Gu, J., D. Chen, J. Rosenblum, R. M. Rubin, and Z. M. Yuan. 2000. Identification of a sequence element from p53 that signals for Mdm2-targeted degradation. Mol. Cell. Biol. 20:1243–1253.
   PubMedGoogle Scholar
• Gu, J., L. H. Nie, H. Kawai, and Z. M. Yuan. 2001. Subcellular distribution of p53 and p73 are differentially regulated by MDM2. Cancer Res. 61:6703–6707.
   PubMedGoogle Scholar
• Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25–27.
   PubMed Web of Science ®Google Scholar
• Jeffrey, P. D., S. Gorina, and N. P. Pavletich. 1995. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267:1498–1502.
   PubMed Web of Science ®Google Scholar
• Kaghad, M., H. Bonnet, A. Yang, L. Creancier, J. C. Biscan, A. Valent, A. Minty, P. Chalon, J. M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809–819.
   PubMed Web of Science ®Google Scholar
• Lain, S., C. Midgley, A. Sparks, E. B. Lane, and D. P. Lane. 1999. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp. Cell Res. 248:457–472.
   PubMed Web of Science ®Google Scholar
• Lee, W., T. S. Harvey, Y. Yin, P. Yau, D. Litchfield, and C. H. Arrowsmith. 1994. Solution structure of the tetrameric minimum transforming domain of p53. Nat. Struct. Biol. 1:877–890.
   PubMedGoogle Scholar
• Liang, S. H., and M. F. Clarke. 1999. The nuclear import of p53 is determined by the presence of a basic domain and its relative position to the nuclear localization signal. Oncogene 18:2163–2166.
   PubMedGoogle Scholar
• Lohrum, M. A., D. Woods, R. L. Ludwig, and K. H. Vousden. 2001. C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 21:8521–8532.
   PubMedGoogle Scholar
• Lohrum, M. A., and K. H. Vousden. 2000. Regulation and function of the p53-related proteins: same family, different rules. Trends Cell Biol. 10:197–202.
   PubMed Web of Science ®Google Scholar
• Middeler, G., K. Zerf, S. Jenovai, A. Thulig, M. Tschodrich-Rotter, U. Kubitscheck, and R. Peters. 1997. The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene 14:1407–17.
   PubMedGoogle Scholar
• Nakamura, S., J. A. Roth, and T. Mukhopadhyay. 2000. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol. Cell. Biol. 20:9391–9398.
   PubMedGoogle Scholar
• Rodriguez, M. S., J. M. Desterro, S. Lain, D. P. Lane, and R. T. Hay. 2000. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol. Cell. Biol. 20:8458–8467.
   PubMed Web of Science ®Google Scholar
• Stommel, J. M., N. D. Marchenko, G. S. Jimenez, U. M. Moll, T. J. Hope, and G. M. Wahl. 1999. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18:1660–1672.
   PubMed Web of Science ®Google Scholar
• Weis, K.. 1998. Importins and exportins: how to get in and out of the nucleus. Trends Biochem. Sci. 23:185–189.
   PubMed Web of Science ®Google Scholar
• Zhu, J., J. Jiang, W. Zhou, and X. Chen. 1998. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58:5061–5065.
   PubMed Web of Science ®Google Scholar